Collegium Pharmaceutical, Inc.
US ˙ NasdaqGS ˙ US19459J1043

SecurityCOLL / Collegium Pharmaceutical, Inc.
InstitutionValues First Advisors, Inc.
Latest Disclosed Ownership17,086 shares
Latest Disclosed Value $ 565,019
Values First Advisors, Inc. reports 0.49% increase in ownership of COLL / Collegium Pharmaceutical, Inc.

On April 17, 2026 - Values First Advisors, Inc. filed a 13F-HR form disclosing ownership of 17,086 shares of Collegium Pharmaceutical, Inc. (US:COLL) valued at $565,034 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 17,003 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 0.49% during the quarter. The current value of the position is $530,691 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 17,086 83 0.49 565 -28.21 0.1015
2026-01-30 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 17,003 -582 -3.31 787 27.97 0.4084
2025-10-21 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 17,585 -864 -4.68 615 12.84 0.3293
2025-07-29 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,449 1,804 10.84 546 9.88 0.2971
2025-04-30 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 16,645 -261 -1.54 497 2.48 0.2896
2025-01-29 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 16,906 -1,506 -8.18 484 -31.93 0.2666
2024-10-23 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,412 1,419 8.35 711 29.98 0.3859
2024-07-19 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 16,993 1,057 6.63 547 -11.49 0.3278
2024-04-23 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,936 -17,929 -52.94 619 -40.69 0.3626
2024-01-18 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 33,865 -9,642 -22.16 1,042 7.20 0.6290
2023-11-08 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 43,507 6,557 17.75 972 22.42 0.6282
2023-08-02 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 36,950 7,325 24.73 794 11.83 0.4793
2023-05-15 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 29,625 -18,003 -37.80 711 -35.69 0.4526
2023-01-20 2022-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 47,628 2,193 4.83 1,105 51.65 0.7711
2022-12-02 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 45,435 -2,652 -5.52 728 -14.55 0.5231
2022-07-20 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 48,087 2,474 5.42 852 -8.29 0.6053
2022-05-03 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 45,613 3,301 7.80 929 17.59 0.5865
2022-03-10 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 42,312 539 1.29 790 -4.24 0.4678
2022-11-15 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 41,773 4,551 12.23 825 -6.25 0.5345
2022-11-15 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 37,222 4,325 13.15 880 12.82 0.5969
2022-11-15 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 32,897 -6,142 -15.73 780 -0.26 0.5758
2022-11-15 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 39,039 7,798 24.96 782 20.31 0.6232
2022-11-15 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 31,241 6,932 28.52 650 52.94 0.5974
2022-11-15 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 24,309 -36 -0.15 425 -99.89 0.4208
2023-01-09 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 24,345 -15,254 -38.52 397,549 48,679.02 0.4772
2022-11-15 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 39,599 39,599 815 0.7867
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.